The FDA has granted Breakthrough Device Designation to Nyxoah SA (NASDAQ: NYXH) Genio bilateral hypoglossal nerve stimulation system. The system treats adult patients with moderate to severe Obstructi
Nyxoah Announc es Participation in the Cantor 2021 Virtual Global Healthcare Conference

Publication relating to transparency notifications

04:30pm, Wednesday, 01'st Sep 2021
PRESS RELEASE

Nyxoah Issues First Half 2021 Financial Results

04:30pm, Tuesday, 31'st Aug 2021
REGULATED INFORMATION
Nyxoah (NYXH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Nyxoah Appoints Rita Johnson-Mills to its Board of Directors
Mont-Saint-Guibert, Belgium. - August 11, 2021, 10:30 pm CET / 4:30 pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the
PRESS RELEASE REGULATED INFO R MATION
PRESS RELEASE
Mont-Saint-Guibert, Belgium – July 2, 2021, 2:40pm CET / 8:40am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the dev
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE